Main Sector
Biotech Subsector
Medtech Subsector
Diagnostics Subsector
Indication
Biotech Phase of Development
Medtech/Diagnostics Phase of Development
Index
Reset

Gigi Ho

A unique not-for-profit, TEC Edmonton is a joint venture of the University of Alberta and the Edmonton Economic Development Corporation. TEC Edmonton helps technology entrepreneurs accelerate their growth. In addition to being the commercialization agent for University of Alberta technologies, TEC Edmonton operates Greater Edmonton's largest accelerator for early stage technology companies, including both university spinoffs and companies from the broader community. TEC Edmonton provides client services in four broad areas: Business development, funding and finance, technology commercialization and entrepreneur development. In 2015, TEC Edmonton was identified by the Swedish University Business Incubator (UBI) Index as the 4th best university business incubator in North America, and was also named Canadian "Incubator of the Year" at the 2014 Startup Canada Awards.

About the TEC Health Accelerator: A program of TEC Business Development, the TEC Health Accelerator connects life sciences startups and researchers with health-service providers like Alberta Health Services, health research funders like Alberta Innovates - Health Solutions, life-science investors and multi-national health care companies looking for new products.

For more information, visit www.tecedmonton.com.

Website:
www.tecedmonton.com
TEC Edmonton
Manager Business Development 

Jean-François Houle

Website:
http://www.nrc-cnrc.gc.ca/
Jean-François Houle
National Research Council
LinkedIn logo Director of R&D 
BIO

Prior to joining the NRC, Dr.Houle had spent 14 years leading business, corporate and product development activities in private and public biotechnology firms at various stages of development from University spin-offs to more established companies. Most recently, as COO of Kapplex, he guided the company through its initial spin-out of the University into a full-fledged funded start-up. Prior to Kapplex, Dr. Houle held a leadership role in product and business development at Axela, a company in the field of multiplexed biomarker detection, leading the successful launch of several products. Dr. Houle began his industrial career at SYNX Pharma, a proteomics and diagnostics company, where he sought out, structured and fostered collaborations and alliances. These activities led to a diagnostic development agreement with Ortho-Clinical Diagnostics and the eventual merger of SYNX with Nanogen Inc. JF holds a Ph.D. in Experimental Medicine from McGill University and holds several patents in the field of biomarker detection.